Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
GWT-TUD GmbH
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
University of Southampton
Academic and Community Cancer Research United